Earning Preview: Ingersoll Rand Inc. this quarter’s revenue is expected to increase by 6.25%, and institutional views are predominantly bullish

Earnings Agent
04/22

Abstract

Ingersoll Rand Inc. will report results on April 28, 2026 Post Market; consensus points to revenue of 1.83 billion US dollars and adjusted EPS of 0.74, with margin resilience and segment mix shaping investor expectations ahead of the print.

Market Forecast

The market’s current baseline for the upcoming quarter anticipates revenue of 1.83 billion US dollars, implying 6.25% year-over-year growth, and adjusted EPS of 0.74, up 0.90% year over year; EBIT is projected at 395.92 million US dollars, a modest 0.25% year-over-year decline. Forecast gross profit margin and net profit margin are not formally provided within the available dataset, so margin commentary remains qualitative heading into the report.

Within the company’s core operations, the revenue mix in the last reported quarter was anchored by Industrial Technologies and Services at 1.67 billion US dollars and complemented by Precision and Science Technologies at 419.00 million US dollars; execution focus this quarter centers on sustaining price/mix discipline and cost controls to protect profitability as volumes normalize. Precision and Science Technologies is viewed as the most promising growth vector: using the consolidated forecast as a reference, the segment enters the quarter with 419.00 million US dollars of recent revenue and is expected to grow at or above the company-level pace of approximately 6.25% year over year, contingent on mix and order conversion.

Last Quarter Review

In the prior quarter, Ingersoll Rand Inc. delivered 2.09 billion US dollars of revenue (up 10.14% year over year), a 42.59% gross profit margin, GAAP net profit attributable to the company of 266.00 million US dollars, a 12.72% net profit margin, and adjusted EPS of 0.96 (up 14.29% year over year). One notable highlight was profitability momentum: net profit increased by 9.01% quarter on quarter, while revenue beat the quarter’s consensus by 51.87 million US dollars, underpinned by solid contribution from both segments and healthy operational leverage.

Main business contributions were led by Industrial Technologies and Services at 1.67 billion US dollars (approximately 80% of mix) and Precision and Science Technologies at 419.00 million US dollars (about 20%), collectively supporting the group’s 10.14% year-over-year revenue growth for the period through a combination of price realization, service attachment, and recent acquisitions.

Current Quarter Outlook

Core Industrial Technologies and Services

For the upcoming quarter, the central watchpoint in Industrial Technologies and Services is price realization versus volume elasticity. The last reported period’s gross profit margin of 42.59% sets a high bar; management discipline on pricing, combined with moderating input costs and procurement savings, should allow the segment to protect contribution margins even as year-over-year growth moderates to a mid-single-digit range at the consolidated level. Mix will matter: a greater share of services, parts, and aftermarket solutions generally boosts incremental margins and cushions cyclical fluctuations, so investors will track the degree to which the installed base monetization offsets any pacing in new equipment orders.

Operationally, the segment’s scale enables cost absorption benefits and productivity gains, which can show up in consolidated EBIT even if revenue grows at a measured pace. The 0.25% year-over-year dip in projected EBIT for the group signals that fixed-cost absorption may be slightly less favorable this quarter versus a robust prior-year comparison; however, continuous cost actions and simplification of the footprint can mitigate that headwind. Working capital efficiency and delivery performance are additional swing factors. Shorter cycle times and tighter cash conversion can support free cash flow quality, reinforcing the capacity for reinvestment and capital deployment without compromising near-term earnings.

Another focal area is the trajectory of orders and backlog conversion within the core. Stable order intake at normalized levels can keep production scheduling efficient and reduce overtime or expedited freight costs. If the service mix skews higher than seasonal norms, it can uplift margins even with modest top-line growth, given the inherently accretive profile of services and parts. Conversely, if customers pace orders later in the quarter, revenue timing could skew toward the back half of the period, leaving price/mix as the primary buffer for profitability.

Precision and Science Technologies

Precision and Science Technologies remains the most promising growth contributor within the portfolio. With 419.00 million US dollars of revenue in the last reported quarter, this segment benefits from a product set that typically favors premium mix, engineered solutions, and high-value aftermarket support. That combination often delivers attractive gross margins and supports earnings quality when consolidated EBIT faces tougher year-over-year comparisons. As consensus expects consolidated revenue to grow 6.25% year over year in the quarter, this segment is well placed to track at or above that pace if order conversion and backlog execution remain orderly.

On the cost side, the segment’s profitability depends heavily on throughput and loadings in specialized operations. Efficient scheduling, yields, and scrap control in high-spec production can translate to better incremental margins, meaning even a modest volume uplift can produce a measurable EBITDA contribution. Any recent acquisition tuck-ins—integrated cleanly—can further help by adding niche capabilities and cross-selling opportunities into the broader customer base. Service attachment in this segment, similar to the core, amplifies both revenue visibility and margin, particularly when tied to preventive maintenance and performance optimization contracts that smooth quarter-to-quarter variability.

Mix within this segment can also influence the consolidated EPS progression. If product categories with higher average selling prices and comparatively stronger margins execute on time, the modest 0.90% expected increase in adjusted EPS can be met or marginally exceeded, even with EBIT down 0.25% year over year. Conversely, any timing delays in deliveries of higher-ticket items push more of the earnings contribution into subsequent quarters, emphasizing the importance of on-time delivery and supply continuity. In the near term, management’s ability to align production and logistics to demand patterns, while maintaining price integrity, will be crucial to sustaining the last quarter’s 42.59% gross margin baseline at the company level.

Key Stock Price Drivers This Quarter

The first determinant of share reaction will be the revenue print relative to the 1.83 billion US dollars consensus. A beat-or-meet on top line, combined with a stable margin narrative, would validate the underlying price/mix strategy and support the modest 0.90% year-over-year EPS growth embedded in expectations. Investors will be highly attuned to quality-of-revenue details—namely, the proportion of services, aftermarket, and recurring revenue elements—because these typically command higher margins and offer better earnings visibility across cycles.

Margin commentary will be the second catalyst. The reported 42.59% gross margin in the last quarter is elevated versus historical averages, so the market will scrutinize sustainability. If management signals durable price capture, a favorable product mix, and a balanced volume environment, the share price could respond positively even if EBIT is roughly in line with the 395.92 million US dollars projection. Conversely, if EBIT undershoots due to mix or fixed-cost absorption while gross margin holds, investors may look through a single quarter of softness provided the qualitative margin outlook and backlog quality remain constructive.

Finally, capital deployment and operating discipline round out the near-term stock drivers. Previous-quarter revenue outperformance by 51.87 million US dollars and the 9.01% quarter-on-quarter growth in net profit demonstrate operating momentum entering this quarter. The market will look for confirmation that cash conversion, returns on invested capital, and integration of recent tuck-ins continue to trend in the right direction. Commentary on the timing and scale of the acquisition pipeline, along with ongoing operational excellence initiatives, can influence how investors extrapolate the remainder of the year beyond this quarter’s modest EPS growth profile.

Analyst Opinions

Across the commentary available from January 1, 2026 through April 21, 2026, the balance of views leans bullish. Counting only items in this period, there are three bullish opinions (Buy/Outperform/Overweight) versus two cautious opinions (Equalweight/Hold), indicating a predominantly bullish stance. The majority view emphasizes a constructive setup into the print, with incremental focus on pricing durability, segment mix, and capital deployment.

On the bullish side, several institutions have reiterated favorable views while adjusting price targets. Citigroup maintained a Buy rating and raised its price target to 113 US dollars, citing confidence in execution and earnings durability through disciplined pricing and balanced capital allocation. Baird maintained an Outperform rating with a 112 US dollars price target update, highlighting the earnings quality benefits of mix and the value-creation potential from ongoing operational improvements and bolt-on integration. Barclays maintained an Overweight rating and set a 100 US dollars price target in an early-April update, underscoring that margin management and the structure of the revenue base continue to support a premium to peers on earnings resilience and free cash flow characteristics.

The majority view coalesces around a few shared themes. First, price/mix integrity is viewed as intact, supporting above-average margins even as year-over-year revenue growth normalizes to mid-single-digits this quarter. Second, analysts point to the earnings compounding potential from the portfolio structure: the combination of a large, service-rich core and a higher-value precision and science technology set positions the consolidated margin to remain robust across different volume scenarios. Third, capital deployment remains a supportive backdrop, with a preference for high-return, bolt-on transactions and disciplined shareholder returns that keep leverage and liquidity balanced without sacrificing optionality.

In the context of the quarter’s numbers, the bullish camp sees the 1.83 billion US dollars revenue estimate as achievable, with upside potential stemming from favorable mix in both core and precision segments. Even with EBIT forecast to be down 0.25% year over year, they expect gross margin to remain at a healthy level relative to the 42.59% achieved last quarter, which would allow adjusted EPS to land near or slightly above the 0.74 consensus, up 0.90% year over year. The prior quarter’s beat on revenue by 51.87 million US dollars and quarter-on-quarter net profit improvement of 9.01% add confidence to this view, as they demonstrate operational momentum that can carry into the current period.

Looking beyond the single quarter, bullish analysts frame the story around durability. They point to the recurring aspects of the revenue model—especially services and aftermarket—as key supports for margin consistency and cash generation. They also argue that the precision-focused portfolio extension enhances structural growth and margin potential, making consolidation of recent acquisitions and cross-selling into the broader customer base a meaningful lever for sustained EPS progression. With a near-term forecast of 6.25% year-over-year growth in revenue and a 0.90% increase in adjusted EPS, the investment case hinges on operational excellence and disciplined capital allocation as mechanisms to maintain earnings quality through varying demand conditions.

In sum, the prevailing analyst stance ahead of April 28, 2026 is positive. The consensus expects mid-single-digit top-line growth and steady EPS, with the balance of opinion suggesting that execution on price, mix, and cost controls can bridge what appears to be a slightly tougher EBIT comparison. For investors tracking the setup, the majority view is that a confirmatory print on revenue and a stable margin outlook would validate the near-term expectations and sustain constructive sentiment around the stock’s earnings trajectory.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10